Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis
NCT00069186
·
clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
107
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis (ALS)
Interventions
DRUG:
Creatine Monohydrate
Sponsor
The Avicena Group